U.S. FDA CHIEF ON DRUGMAKERS: IF BUILD IN U.S., WILL ALSO MOVE TO FRONT OF LINE

U.S. FDA CHIEF ON DRUGMAKERS: IF BUILD IN U.S., WILL ALSO MOVE TO FRONT OF LINE

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)